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The Concept of a Scientific Fact
In Opus Tertium (1267) Roger Bacon distin-
guishes experimental science by:
1. verification of conclusions by direct
experiment,
2. discovery of truths unreachable by other
approaches,
3. investigation of the secrets of nature,
opening us to a knowledge of past and
future.
I described a repeating cycle of observation, hypothesis,
experimentation, and the need for independent verification,
I recorded his experiments (e.g. the nature and cause of the
rainbow) in enough detail to permit reproducibility by others.
3 / 30
The Changing Concept of a Scientific Fact
International Strategy Meetings on Human DNA Sequencing




In Novum Organum (1620) Francis Bacon proposes:
1. the gathering of facts, by observation or
experimentation,
2. verification of general principles.
“There are and can be only two ways of
searching into and discovering truth. The
one flies from the senses and particulars to
the most general axioms, and from these
principles, the truth of which it takes for
settled and immoveable. ... The other
derives axioms from the senses and par-
ticulars, rising by a gradual and unbroken
ascent, so that it arrives at the most gen-
eral axioms last of all. This is the true
way, but as yet untried.”
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I The Royal Society of London founded
1660 (the “Invisible College”),
I members discussed Francis Bacon’s
“new science” from 1645,
I Society correspondence reviewed by
the first Secretary, Henry Oldenburg,
I Oldenburg became the founder, editor,
author, and publisher of Philosophical
Transactions, launched in 1665.
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The Last Update to the Scientific Method: 1665
I The “Invisible College” included Robert
Boyle, the “father of chemistry,”
I Boyle introduced standards for scientific
communication: enough information
must be included to allow others to
independently reproduce the finding.
I delineates science, concept of
reproducibility permits verification and
knowledge transfer,
I knowledge in method not in the finding
itself.
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Controlling Error is Central to Scientific Progress
“The scientific method’s central motivation is the ubiquity of error
- the awareness that mistakes and self-delusion can creep in
absolutely anywhere and that the scientist’s effort is primarily
expended in recognizing and rooting out error.”
David Donoho et al. (2009)
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The Third Branch of the Scientific Method
I Branch 1: Deductive/Theory: e.g. mathematics; logic,
I Branch 2: Inductive/Empirical: e.g. the machinery of
hypothesis testing; statistical analysis of controlled
experiments,
I Branch 3? 4? Large scale extrapolation and prediction, using
simulation and other data-intensive methods.
8 / 30
The Changing Concept of a Scientific Fact
International Strategy Meetings on Human DNA Sequencing




The Changing Concept of a Scientific Fact
International Strategy Meetings on Human DNA Sequencing
Duke Clinical Trial Experience
Other Experiences
Examples
Scientific Research is Changing
Scientific computation emerging as central to the scientific
method:
I Simulation of the complete evolution of a physical system,
systematically changing parameters,
I (Massive) data driven research, machine-generated
hypotheses.
Thesis: Computational science cannot be elevated to a third
branch of the scientific method until it generates routinely
verifiable knowledge. (Donoho, et al. 2009)
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I. Examples of Pervasiveness of Computational Methods
I For example, in statistics:
JASA June Computational Articles Code Publicly Available
1996 9 of 20 0%
2006 33 of 35 9%
2009 32 of 32 16%
2011 29 of 29 21%
I Social network data and the quantitative revolution in social
science (Lazer et al. 2009);
I Computation reaches into traditionally nonquantitative fields:
e.g. Wordhoard project at Northwestern examining word
distributions by Shakespearian play.
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2. Dynamic modeling of macromolecules: SaliLab UCSF
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3. Mathematical “proof” by simulation and grid search
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Toward Transparency in Computational Science
Examples of influential steps toward transparency in dissemination
of results:
I data sharing standards in bioinformatics,
I Institute of Medicine’s recommendation for open (and fixed)
code requirements for the FDA,
I geophysics and statistics.
A complete accounting is impossible in this talk...
14 / 30
The Changing Concept of a Scientific Fact
International Strategy Meetings on Human DNA Sequencing







The 1996 Bermuda Agreement
Primary Genomic Sequence Should be in the Public Domain
It was agreed that all human genomic sequence information,
generated by centers funded for large-scale human sequencing,
should be freely available and in the public domain in order to
encourage research and development and to maximize its benefit
to society.
Primary Genomic Sequence Should be Rapidly Released
I Sequence assemblies should be released as soon as possible; in
some centers, assemblies of greater than 1 Kb would be
released automatically on a daily basis.
I Finished annotated sequence should be submitted immediately
to the public databases.
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Bermuda 1997 and 1998
Bermuda 1997 provided agreed standards on error rates and details
on submission and annotation. Created a one year maximum claim
on a sequence.
Bermuda 1998 extended the human data release principles to other
organisms. (not adopted by funding agencies as previous
agreements had been.)
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The 2003 Fort Lauderdale Agreement
About 40 stakeholders reaffirm Bermuda 1996, and recommend
further that:
I Bermuda be extended to apply to all sequence data, including
both the raw traces and whole genome shotgun assemblies,
I the principle of rapid pre-publication release should apply to
other types of data from other large-scale production centers
specifically established as “community resource projects” (ie.
International Human Genome Sequencing Consortium, the
Mouse Genome Sequencing Consortium, the Mammalian Gene
Collection, the SNPs Consortium, and the International
HapMap Project)
I pre-publication data release requires community-wide support
due to the incentive to publish the first analysis of one’s own
data.
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The 2003 Fort Lauderdale Agreement
Introduces the notion of “Tripartite Sharing of Responsibility”
Summary:
I Funding Agencies: require free and unrestricted data release
from community projects in central and searchable databases,
I Resource Producers: publish a Project Description, and make
immediate availability of well-described, high quality data,
I Resource Users: cite data sources appropriately, possibly
through the Project Description.
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The 2008 Amsterdam Agreement
Extends the principle of rapid data release to proteomics data.
Since many center and funding agencies outside the the
mainstream remain unaware of these agreements, they are affirmed
in Toronto in May 2009.
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The 2009 Toronto Agreement
Goals:
I continued policy discussions from the Bermuda and Fort
Lauderdale agreements,
I endorsed the value of rapid prepublication data release for
large reference data sets in biology and medicine that have
broad utility,
I prepublication data release should go beyond genomics and
proteomics studies to other data sets and annotated clinical
resources (a range of project sizes, minimum standard should
be data release at publication),
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The 2009 Toronto Agreement
Building on Fort Lauderdale 2003,
I Funding Agencies: announce release requirements; peer review
includes dataset release plans; provide help to develop
appropriate consent, security, access and governance
mechanisms; provide long-term support of databases,
I Data Producers: publish a citable marker paper with dataset
information; simultaneous release of relevant metadata; create
databases with all versions archived, including raw data,
I Resource Users: allow data producers first analysis, cite data
sources accurately and completely, be aware early data may be
subject to later quality improvements,
I Scientific Journal Editors: provide guidance to authors and
reviewers on the third-party use of prepublication data in
manuscripts.
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The Bioinformatics experience frames public understanding
Conjecture: Much of the public (Congressional and Whitehouse)
understanding of scientific transparency stems from the experience
in bioinformatics: the focus is on open data, rather than
reproducibility or transparency.
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Clinical trials based on flawed genomic studies
Timeline:
I Potti et al (2006), Nature Medicine; (2006) NEJM; (2007)
Lancet Oncology; (2007) Journal of Clinical Oncology:
evidence of genomic signatures to guide use of
chemotheraputics (all since retracted),
I Coombes, Wang, Baggerly at M.D. Anderson Cancer Center
cannot replicate, and find flaws: genes misaligned by one row,
column labels flipped, genes repeated and missing from
analysis..
I 2007 correspondence and a supplementary report submitted to
the Journal of Clinical Oncology and publication declined;
2008 Nature Medicine declines their correspondence.
I Clinical trials initiated in 2007 (Duke), 2008 (Moffitt).
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Clinical trials based on flawed genomic studies
I Duke launches internal investigation Sept 2009; all three trials
suspended in Oct 2009,
I Oct 2009: results reported validated, regardless of errors,
because data blinded (later found not to be true),
I Jan 2010: Duke clinical trials resume, patients allocated to
treatment and control groups. “Neither the review nor the
raw data are being made available at this time.”
I July 2010: 33 prominent biostatisticians write to Varmus as
head of IOM urging suspension of the trials and an
examination of standards of review, including reproducibility.
I Sept 2010: IOM committee “Review of Omics-Based Tests for
Predicting Patient Outcomes in Clinical Trials” formed,
I late 2010: Potti resigns, Nevins removed from position, and
the clinical trials are terminated.
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Recommendations from the Institute of Medicine
I March 23, 2012, IOM releases report, “Evolution of
Translational Omics: Lessons Learned and the Path Forward”
I Recommends new standards for omics-based tests, including a
fixed version of the software, expressly for verification
purposes.
25 / 30
The Changing Concept of a Scientific Fact
International Strategy Meetings on Human DNA Sequencing
Duke Clinical Trial Experience
Other Experiences
IOM Report: Figure S-1
“The fully specified computational procedures are locked down in
the discovery phase and should remain unchanged in all subsequent
development steps.”
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Experience in Geophysics and Statistics
I 1991: Stanford Professor Jon Claerbout requires theses to
conform to standard of reproducibility,
I reduces ”startup time” for new students from years to weeks,
I his vision adopted and adapted by many others, e.g. Sergey
Fomel, David Donoho.
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Madagascar (Sergey Fomel and collaborators)
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Grassroots Efforts in Many Fields, Policies
Independent efforts by researchers:
I ICERM 2012 “Reproducibility in Computational and Experimental Mathematics”
I AMP 2011 “Reproducible Research: Tools and Strategies for Scientific Computing”
I AMP / ICIAM 2011 “Community Forum on Reproducible Research Policies”
I SIAM Geosciences 2011 “Reproducible and Open Source Software in the Geosciences”
I ENAR International Biometric Society 2011: Panel on Reproducible Research
I AAAS 2011: “The Digitization of Science: Reproducibility and Interdisciplinary Knowledge Transfer”
I SIAM CSE 2011: “Verifiable, Reproducible Computational Science”
I Yale 2009: Roundtable on Data and Code Sharing in the Computational Sciences
I ACM SIGMOD conferences
I ...
Policy changes:
I NSF/OCI report on Grand Challenge Communities (Dec 2010)
I NSF report “Changing the Conduct of Science in the Information Age” (Aug 2011)
I IOM “Review of Omics-based Tests for Predicting Patient Outcomes in Clinical Trials” (2012)
I NIH, NSF multiple requests for input on data policies
I Journal policy movement toward code and data requirements (ie. Science Feb 2011)
I ...
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